NCT04982367View on ClinicalTrials.gov

Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis

NARecruitingINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

December 8, 2021

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Peripheral Artery Disease
Interventions
DEVICE

Sirolimus-eluting balloon catheter

Sirolimus-eluting balloon catheter designed and produced by Acotec

DEVICE

Paclitaxel-eluting balloon catheter

Paclitaxel-eluting balloon catheter (trade name:DHALIA)

Trial Locations (1)

100039

RECRUITING

Chinese PLA General Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Acotec Scientific Co., Ltd

INDUSTRY

NCT04982367 - Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis | Biotech Hunter | Biotech Hunter